At-home HPV testing boosts cervical cancer screening participation

Mailed at-home self-sampling for human papillomavirus (HPV) testing will increase cervical most cancers screening participation in underscreened populations by nearly threefold, based on a examine offered on the annual assembly of the American Affiliation for Most cancers Analysis, held from April 5 to 10 in San Diego.

Jane R. Montealegre, Ph.D., from the College of Texas MD Anderson Most cancers Heart in Houston, and colleagues evaluated the effectiveness of mailed at-home self-sampling for HPV testing in a safety-net well being system setting. The evaluation included information from 2,115 sufferers who have been randomly assigned to one of many three following arms: phone recall to provider-performed screening (standard care; arm 1); phone recall + mailed self-sampling equipment for HPV testing (arm 2); or phone recall + mailed self-sampling equipment + telephone-based affected person navigation (arm 3).

The researchers discovered that amongst individuals, the median time since final screening check was 9.5 years. Screening participation throughout arms 1, 2, and three was 15.3, 44.0, and 51.4 %, respectively. In contrast with standard care (arm 1), the relative incidence of screening in arms 2 and three was 2.90 and three.36, respectively. For arm 3 versus arm 2, the relative incidence of screening was 1.16.

“After U.S. Meals and Drug Administration approval, self-sampling for high-risk-HPV testing has the potential to dramatically enhance participation in cervical cancer screening in underserved populations,” the authors write.

Copyright © 2024 HealthDay. All rights reserved.